IntegrativePractitioner.com industry analysis and commentary. Views expressed are of the authors only.
The World Health Organization (WHO) declared an end to its designation of COVID-19 as a global health emergency on Friday.
Due to a decreasing trend… Read More
Attention Deficit Hyperactivity Disorder (ADHD) affects an estimated 9-13% of kids and 8% of adults in the U.S. each year. There is an… Read More
The Integrative Healthcare Symposium (IHS) is accepting proposals to present at the 2024 Integrative Healthcare Symposium, which will be… Read More
The National Center for Complementary and Integrative Health (NCCIH) and the National Institute on Aging (NIA) recently announced a new web-based… Read More
Robert Rountree, MD, joins Integrative Practitioner associate editor, Avery St. Onge, to discuss the different causes of irritable bowel syndrome,… Read More
Semaglutide, tradename Ozempic, is an injectable drug that people with type 2 diabetes take weekly to control their blood sugar levels. It also… Read More
Integrative Practitioner is pleased to offer the Complete Conference Package, featuring
Join Betsy Redmond, Ph.D., MMSc, RDN, on June 15 at 2 PM ET as she explains how to use the OMX™ Organic Metabolomics profile to identify… Read More